| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 641.75 | 402.41 | 283.13 | 232.48 |
| Cash Equivalents | 1.13 | 0.55 | 0.14 | 11.72 |
| Other Liabilities Total | 0.53 | 0.49 | 0.09 | 0.06 |
| Accrued Expenses | 0.02 | - | - | - |
| Long Term Debt | 28.37 | 10.46 | 10.49 | 12.79 |
| Common Stock Total | 24.07 | 24.07 | 24.07 | 24.07 |
| Other Equity Total | 0.00 | - | - | - |
| Other Current Assets Total | 27.33 | 27.54 | 31.64 | 30.83 |
| Total Assets | 641.75 | 402.41 | 283.13 | 232.48 |
| Current Portof LT Debt/ Capital Leases | 1.31 | 3.69 | - | - |
| Total Equity | 155.10 | 131.48 | 111.71 | 100.97 |
| Long Term Investments | 42.91 | 28.84 | 12.34 | 12.34 |
| Retained Earnings( Accumulated Deficit) | 131.03 | 107.41 | 87.64 | 76.91 |
| Total Common Shares Outstanding | 24.07 | 24.07 | 24.07 | 24.07 |
| Tangible Book Valueper Share Common Eq | 5.81 | 5.30 | 4.44 | 4.16 |
| Goodwill Net | 5.22 | 3.49 | 4.36 | - |
| Total Liabilities | 486.65 | 270.93 | 171.42 | 131.50 |
| Total Debt | 285.04 | 170.73 | 104.84 | 34.10 |
| Short Term Investments | 9.72 | 1.50 | 1.50 | - |
| Cashand Short Term Investments | 10.86 | 2.05 | 1.64 | 11.72 |
| Total Receivables Net | 233.34 | 164.77 | 122.55 | 81.51 |
| Notes Payable/ Short Term Debt | 255.11 | 156.59 | 94.35 | 21.32 |
| Deferred Income Tax | 0.15 | 0.29 | 0.02 | 0.18 |
| Accounts Receivable- Trade Net | 233.34 | 160.16 | 122.55 | 81.51 |
| Property/ Plant/ Equipment Total- Net | 80.85 | 26.09 | 22.41 | 19.00 |
| Minority Interest | 1.22 | 0.00 | - | - |
| Total Current Liabilities | 456.12 | 259.69 | 160.82 | 118.48 |
| Total Inventory | 218.74 | 140.48 | 85.74 | 74.57 |
| Accounts Payable | 187.72 | 91.83 | 56.72 | 91.89 |
| Other Currentliabilities Total | 11.97 | 7.59 | 9.76 | 5.27 |
| Total Long Term Debt | 28.63 | 10.46 | 10.49 | 12.79 |
| Intangibles Net | 9.97 | 0.33 | 0.62 | 0.90 |
| Other Long Term Assets Total | 12.54 | 4.25 | - | 0.00 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 490.26 | 334.85 | 241.57 | 198.62 |
| Capital Lease Obligations | 0.26 | - | - | - |
| Note Receivable- Long Term | - | 4.56 | 1.83 | 1.62 |
| Accumulated Depreciation Total | - | - | -3.14 | -2.17 |
| Property/ Plant/ Equipment Total- Gross | - | - | 23.67 | 21.16 |
Sudarshan Pharma Industries Dividend Sudarshan Pharma Industries Bonus Sudarshan Pharma Industries News Sudarshan Pharma Industries AGM Sudarshan Pharma Industries Rights Sudarshan Pharma Industries Splits Sudarshan Pharma Industries Board Meetings Sudarshan Pharma Industries Key Metrics Sudarshan Pharma Industries Shareholdings Sudarshan Pharma Industries Profit Loss Sudarshan Pharma Industries Cashflow Sudarshan Pharma Industries Q1 Results Sudarshan Pharma Industries Q2 Results Sudarshan Pharma Industries Q3 Results Sudarshan Pharma Industries Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.